الاتحاد الأوروبي -
السويدية -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulär blockade - alla andra terapeutiska produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
السويد -
السويدية -
Läkemedelsverket (Medical Products Agency)
dexamethasone fresenius kabi 4 mg/ml injektions-/infusionsvätska, lösning
fresenius kabi ab - dexametasonnatriumfosfat - injektions-/infusionsvätska, lösning - 4 mg/ml - dexametasonnatriumfosfat 4,37 mg aktiv substans
الاتحاد الأوروبي -
السويدية -
EMA (European Medicines Agency)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulär blockade - alla andra terapeutiska produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
الاتحاد الأوروبي -
السويدية -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulär blockade - alla andra terapeutiska produkter - reversering av neuromuskulär blockad som induceras av rocuronium eller vekuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
الاتحاد الأوروبي -
السويدية -
EMA (European Medicines Agency)
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - neuromuskulär blockade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
الاتحاد الأوروبي -
السويدية -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskulär blockade - alla andra terapeutiska produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
السويد -
السويدية -
Läkemedelsverket (Medical Products Agency)
plegicil vet. 10 mg/ml injektionsvätska, lösning
pharmaxim ab - acepromazinmaleat - injektionsvätska, lösning - 10 mg/ml - acepromazinmaleat 13,6 mg aktiv substans - acepromazin - hund, häst
السويد -
السويدية -
Läkemedelsverket (Medical Products Agency)
xanor 0,25 mg tablett
upjohn eesv - alprazolam - tablett - 0,25 mg - natriumbensoat hjälpämne; laktosmonohydrat hjälpämne; alprazolam 0,25 mg aktiv substans - alprazolam
السويد -
السويدية -
Läkemedelsverket (Medical Products Agency)
alprazolam stada 0,25 mg tablett
stada arzneimittel ag - alprazolam - tablett - 0,25 mg - natriumbensoat hjälpämne; laktosmonohydrat hjälpämne; alprazolam 0,25 mg aktiv substans - alprazolam
السويد -
السويدية -
Läkemedelsverket (Medical Products Agency)
alprazolam orion 0,25 mg tablett
orion corporation - alprazolam - tablett - 0,25 mg - laktosmonohydrat hjälpämne; alprazolam 0,25 mg aktiv substans - alprazolam